Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-788.2%
operating margin TTM
-814.58%
revenue TTM
74.80 Million
revenue per share TTM
0.19$
valuation ratios | |
|---|---|
| pe ratio | -4.39 |
| peg ratio | 0.52 |
| price to book ratio | 1.97 |
| price to sales ratio | 40.71 |
| enterprise value multiple | -6.73 |
| price fair value | 1.97 |
profitability ratios | |
|---|---|
| gross profit margin | 10.66% |
| operating profit margin | -814.58% |
| pretax profit margin | -790.4% |
| net profit margin | -788.2% |
| return on assets | -32.0% |
| return on equity | -72.85% |
| return on capital employed | -37.98% |
liquidity ratio | |
|---|---|
| current ratio | 3.81 |
| quick ratio | 3.81 |
| cash ratio | 3.17 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 305.18 |
| days of payables outstanding | 150.15 |
| cash conversion cycle | 155.02 |
| receivables turnover | 1.20 |
| payables turnover | 2.43 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.07 |
| debt equity ratio | 0.10 |
| long term debt to capitalization | 0.02 |
| total debt to capitalization | 0.09 |
| interest coverage | -304.71 |
| cash flow to debt ratio | -3.31 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.11 |
| cash per share | 1.77 |
| operating cash flow per share | -1.07 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -3.31 |
| short term coverage ratios | -42.63 |
| capital expenditure coverage ratio | -25.57 |
Frequently Asked Questions
When was the last time Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) reported earnings?
Recursion Pharmaceuticals, Inc. (RXRX) published its most recent earnings results on 06-11-2024.
What is Recursion Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)'s trailing twelve months ROE is -72.85%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Recursion Pharmaceuticals, Inc. (RXRX) currently has a ROA of -32.0%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RXRX's net profit margin stand at?
RXRX reported a profit margin of -788.2% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RXRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.81 in the most recent quarter. The quick ratio stood at 3.81, with a Debt/Eq ratio of 0.10.